The Across Health Maturometer is back for its 13th edition!
Is C19 accelerating the shift – 12 months into the pandemic?
The most widely referenced research on the state of digital maturity in the life sciences is back for its 13th edition. PARTICIPATE NOW to get a unique view into key trends in the space of digital transformation and omnichannel excellence – a year after C19 hit.
What’s in it for you?
After completing the survey, you can immediately benchmark your results vs key industry trends in 2020 – and once the survey is closed, you will receive an updated report vs the 2021 benchmark. Just like last year, companies with 15 or more respondents will receive a Digital Maturity benchmark. Finally, five lucky-draw participants will receive a fun Google Nest audio pack.
The survey will close on April 30th. We’re looking forward to receiving your answers!
Start the survey NOW!
New on "Innovation strategy": Scala365™
Climbing the ladder of campaign excellence
In view of the strong need for reskilling & upskilling, we extended our successful Excellerator elearning platform into a highly interactive multidisciplinary capability-building platform for omnichannel engagement excellence in biopharma.
Launched in October 2020, Scala365™ includes 15 elearning modules, channel guides, checklists, cases, playbooks, and all the resources needed to boost achieving skill-building at scale.
To further optimize the learning and user experience we will soon add even more features to our platform, including artificial intelligence, gamification, advance reporting, and certification.
Ready to improve the omnichannel customer engagement capabilities at your company?
Show me Scala365™
Featured Offering: Navigator365™
Why our Navigator365™ platform is your new “licence to operate”
This is the time to start reimagining the future of customer engagement. And any strategy will have to be supported by robust facts. Our feature-rich, cloud-based Navigator365™ platform lends itself uniquely to this challenge.
Historic mix data may well have lost most of their value. Fresh data will be your “licence to operate” in the next normal.
We pride ourselves on the fact that Navigator is not “research for research’s sake”, but a very actionable component of your strategy, execution optimization and impact measurement.
Stay ahead of the competition and discover why 40+ pharma companies are using the data…